Trials / Completed
CompletedNCT01452841
A Grapefruit Feeding Trial in Healthy, Overweight Adults
Efficiency of Daily Grapefruit Exposure in Reducing Body Weight and Inflammatory Markers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, though there is some evidence of health promotional effects regarding blood pressure and lipid profiles. The aims of this randomized controlled trial are to determine the role of grapefruit in: 1. Reducing weight 2. Reducing blood pressure 3. Reducing inflammation 4. Improving the lipid profile. The investigators hypothesize that six weeks of daily consumption of grapefruit will reduce weight, blood pressure, and inflammation while improving the lipid profile in overweight, healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Grapefruit | 1.5 Rio Red Grapefruit consumed daily for 6 weeks |
| OTHER | Control | Participants followed a diet low in bioactive rich fruits and vegetables and avoided citrus for six weeks |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2011-10-17
- Last updated
- 2011-10-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01452841. Inclusion in this directory is not an endorsement.